These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11595296)

  • 21. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.
    van Die I; van Vliet SJ; Nyame AK; Cummings RD; Bank CM; Appelmelk B; Geijtenbeek TB; van Kooyk Y
    Glycobiology; 2003 Jun; 13(6):471-8. PubMed ID: 12626400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN.
    Wu L; Bashirova AA; Martin TD; Villamide L; Mehlhop E; Chertov AO; Unutmaz D; Pope M; Carrington M; KewalRamani VN
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1568-73. PubMed ID: 11818554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus.
    Pöhlmann S; Baribaud F; Lee B; Leslie GJ; Sanchez MD; Hiebenthal-Millow K; Münch J; Kirchhoff F; Doms RW
    J Virol; 2001 May; 75(10):4664-72. PubMed ID: 11312337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN.
    Park CG; Takahara K; Umemoto E; Yashima Y; Matsubara K; Matsuda Y; Clausen BE; Inaba K; Steinman RM
    Int Immunol; 2001 Oct; 13(10):1283-90. PubMed ID: 11581173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1.
    Lue J; Hsu M; Yang D; Marx P; Chen Z; Cheng-Mayer C
    J Virol; 2002 Oct; 76(20):10299-306. PubMed ID: 12239306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models.
    Berzi A; Reina JJ; Ottria R; Sutkeviciute I; Antonazzo P; Sanchez-Navarro M; Chabrol E; Biasin M; Trabattoni D; Cetin I; Rojo J; Fieschi F; Bernardi A; Clerici M
    AIDS; 2012 Jan; 26(2):127-37. PubMed ID: 22045343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN.
    Mukhtar M; Harley S; Chen P; BouHamdan M; Patel C; Acheampong E; Pomerantz RJ
    Virology; 2002 May; 297(1):78-88. PubMed ID: 12083838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene for chinese rhesus macaque DC-SIGN predicts the existence of A but not B isoforms of the protein.
    Santos PR; Petitprez K; Butor C
    AIDS Res Hum Retroviruses; 2002 Sep; 18(13):977-81. PubMed ID: 12230940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission.
    Geijtenbeek TB; van Kooyk Y
    Curr Top Microbiol Immunol; 2003; 276():31-54. PubMed ID: 12797442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
    Cole KS; Alvarez M; Elliott DH; Lam H; Martin E; Chau T; Micken K; Rowles JL; Clements JE; Murphey-Corb M; Montelaro RC; Robinson JE
    Virology; 2001 Nov; 290(1):59-73. PubMed ID: 11883006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.
    Luallen RJ; Fu H; Agrawal-Gamse C; Mboudjeka I; Huang W; Lee FH; Wang LX; Doms RW; Geng Y
    J Virol; 2009 May; 83(10):4861-70. PubMed ID: 19264785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of anti-DC-SIGN monoclonal antibodies capable of blocking HIV-1 gp120 binding and reactive on formalin-fixed tissue.
    Canard B; Vachon H; Fontaine T; Pin JJ; Paul S; Genin C; Mueller CG
    Immunol Lett; 2011 Mar; 135(1-2):165-72. PubMed ID: 21078343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The levels of DNGR-1 and its ligand-bearing cells were altered after human and simian immunodeficiency virus infection.
    Yao WR; Li D; Yu L; Wang FJ; Xing H; Yang GB
    Immunol Res; 2017 Aug; 65(4):869-879. PubMed ID: 28478499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients.
    Nair MP; Mahajan SD; Schwartz SA; Reynolds J; Whitney R; Bernstein Z; Chawda RP; Sykes D; Hewitt R; Hsiao CB
    J Immunol; 2005 Jun; 174(11):6617-26. PubMed ID: 15905500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine.
    Robinson JE; Cole KS; Elliott DH; Lam H; Amedee AM; Means R; Desrosiers RC; Clements J; Montelaro RC; Murphey-Corb M
    AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1253-62. PubMed ID: 9764909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of the murine SIGNR1 gene encoding a C-type lectin homologous to human DC-SIGN and DC-SIGNR.
    Parent SA; Zhang T; Chrebet G; Clemas JA; Figueroa DJ; Ky B; Blevins RA; Austin CP; Rosen H
    Gene; 2002 Jun; 293(1-2):33-46. PubMed ID: 12137941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans.
    Pöhlmann S; Soilleux EJ; Baribaud F; Leslie GJ; Morris LS; Trowsdale J; Lee B; Coleman N; Doms RW
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2670-5. PubMed ID: 11226297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression.
    Borggren M; Repits J; Kuylenstierna C; Sterjovski J; Churchill MJ; Purcell DF; Karlsson A; Albert J; Gorry PR; Jansson M
    Retrovirology; 2008 Mar; 5():28. PubMed ID: 18371209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120.
    Lekkerkerker AN; Ludwig IS; van Vliet SJ; van Kooyk Y; Geijtenbeek TB
    Virology; 2004 Nov; 329(2):465-76. PubMed ID: 15518824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1.
    Wang JH; Janas AM; Olson WJ; KewalRamani VN; Wu L
    J Virol; 2007 Mar; 81(5):2497-507. PubMed ID: 17151103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.